Year |
Citation |
Score |
2023 |
Hernandez MC, Yazaki P, Mortimer JE, Yamauchi D, Poku E, Park J, Frankel P, Kim J, Colcher DM, Wong J, Fong Y, Shively J, Woo Y. Pilot study of HER2 targeted 64Cu-DOTA-tagged PET imaging in gastric cancer patients. Nuclear Medicine Communications. PMID 37901917 DOI: 10.1097/MNM.0000000000001761 |
0.322 |
|
2022 |
Fujita N, Handa A, Park JM. Peritumoral Hyperintensity at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI in Hepatic Neuroendocrine Tumors. Anticancer Research. 42: 911-917. PMID 35093889 DOI: 10.21873/anticanres.15549 |
0.321 |
|
2010 |
Cheng Z, De Jesus OP, Kramer DJ, De A, Webster JM, Gheysens O, Levi J, Namavari M, Wang S, Park JM, Zhang R, Liu H, Lee B, Syud FA, Gambhir SS. 64Cu-labeled affibody molecules for imaging of HER2 expressing tumors. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 12: 316-24. PMID 19779897 DOI: 10.1007/S11307-009-0256-6 |
0.467 |
|
2006 |
Krishnan M, Park JM, Cao F, Wang D, Paulmurugan R, Tseng JR, Gonzalgo ML, Gambhir SS, Wu JC. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 106-8. PMID 16246867 DOI: 10.1096/Fj.05-4551Fje |
0.535 |
|
2005 |
Tseng JR, Dandekar M, Subbarayan M, Cheng Z, Park JM, Louie S, Gambhir SS. Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 1851-7. PMID 16269599 |
0.494 |
|
Show low-probability matches. |